MWM
ABBV icon

Mattern Wealth Management’s AbbVie ABBV Stock Holding History

Mattern Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
4,847
+18
+0.4% +$3.87K 0.2% 59
2026
Q1 		$1.05M Sell
4,829
-1,400
-22% -$311K 0.2% 58
2025
Q4 		$1.42M Sell
6,229
-125
-2% -$28.5K 0.27% 52
2025
Q3 		$1.47M Hold
6,354
– – 0.29% 51
2025
Q2 		$1.18M Hold
6,354
– – 0.25% 58
2025
Q1 		$1.33M Sell
6,354
-125
-2% -$24.3K 0.29% 54
2024
Q4 		$1.15M Sell
6,479
-75
-1% -$13.8K 0.25% 66
2024
Q3 		$1.29M Sell
6,554
-1,415
-18% -$264K 0.28% 64
2024
Q2 		$1.37M Sell
7,969
-1,824
-19% -$302K 0.33% 67
2024
Q1 		$1.78M Buy
9,793
+1
+0% +$172 0.43% 69
2023
Q4 		$1.52M Sell
9,792
-99
-1% -$14.4K 0.39% 72
2023
Q3 		$1.47M Buy
9,891
+1
+0% +$147 0.43% 68
2023
Q2 		$1.33M Sell
9,890
-63
-0.6% -$9.24K 0.39% 73
2023
Q1 		$1.59M Sell
9,953
-125
-1% -$19.1K 0.53% 62
2022
Q4 		$1.63M Buy
10,078
+109
+1% +$16.7K 0.66% 55
2022
Q3 		$1.34M Buy
9,969
+150
+2% +$21.5K 0.54% 59
2022
Q2 		$1.5M Sell
9,819
-695
-7% -$106K 0.59% 53
2022
Q1 		$1.7M Sell
10,514
-25
-0.2% -$3.63K 0.56% 54
2021
Q4 		$1.43M Sell
10,539
-15
-0.1% -$1.77K 0.42% 63
2021
Q3 		$1.14M Buy
10,554
+350
+3% +$40K 0.38% 70
2021
Q2 		$1.2M Sell
10,204
-92
-0.9% -$10.4K 0.38% 70
2021
Q1 		$1.11M Buy
10,296
+5
+0% +$535 0.39% 70
2020
Q4 		$1.1M Hold
10,291
– – 0.42% 70
2020
Q3 		$901K Buy
10,291
+200
+2% +$18.8K 0.39% 74
2020
Q2 		$991K Sell
10,091
-950
-9% -$83.6K 0.48% 69
2020
Q1 		$841K Buy
11,041
+2,332
+27% +$199K 0.61% 55
2019
Q4 		$771K Buy
+8,709
New +$723K 0.46% 75

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mattern Wealth Management's ABBV Position: Q2 2026 in Review

Mattern Wealth Management increased its AbbVie (ABBV) stake by 0.37% in Q2 2026, buying an estimated $3.87K and bringing the position to 4,847 shares worth $1.22M. The position accounts for 0.2% of the portfolio, ranked #59.

Mattern Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.78M in Q1 2024. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mattern Wealth Management held 4,847 shares of AbbVie worth $1.22M as of Q2 2026.
  • Mattern Wealth Management bought 18 AbbVie shares in Q2 2026, an estimated $3.87K.
  • AbbVie made up 0.2% of Mattern Wealth Management's portfolio in Q2 2026, its #59 holding.
  • Mattern Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Mattern Wealth Management's AbbVie position peaked at $1.78M in Q1 2024.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mattern Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.